Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis

Clinical trial NCT00594932 · COMPLETED

Trial details

NCT number: NCT00594932
Sponsor: Oklahoma Medical Research Foundation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Arthritis

Start date: 2006-11-01
Primary completion: 2008-07-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.